Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study
dc.contributor.author | Viprakasit, Vip | |
dc.contributor.author | Taher, Ali T. | |
dc.contributor.author | Kattamis, Antonis | |
dc.contributor.author | Porter, John B. | |
dc.contributor.author | Habr, Dany | |
dc.contributor.author | Cappellini, M. Domenica | |
dc.contributor.author | Karakas, Zeynep | |
dc.contributor.author | Zhang, Yiyun | |
dc.contributor.author | Ros, Jacqueline | |
dc.contributor.author | Lawniczek, Tomasz | |
dc.contributor.author | Galanello, Renzo | |
dc.contributor.author | Siritanaratkul, Noppodol | |
dc.contributor.author | Sutcharitchan, Pranee | |
dc.contributor.author | Chuncharunee, Suporn | |
dc.date.accessioned | 2021-03-06T08:32:46Z | |
dc.date.available | 2021-03-06T08:32:46Z | |
dc.identifier.citation | Taher A. T. , Porter J. B. , Viprakasit V., Kattamis A., Chuncharunee S., Sutcharitchan P., Siritanaratkul N., Galanello R., Karakas Z., Lawniczek T., et al., "Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study", 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, California, Amerika Birleşik Devletleri, 10 - 13 Aralık 2011, cilt.118, ss.412-413 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e178e7d2-2f7b-41d3-ac73-17fa15534dc7 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/148435 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | HEMATOLOJİ | |
dc.subject | Hematoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study | |
dc.type | Bildiri | |
dc.contributor.department | American University of Beirut , , | |
dc.identifier.volume | 118 | |
dc.contributor.firstauthorID | 138877 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]